Sage Journals: Discover world-class research

Abstract

Significant subtype-specific differences were observed in the protease (PR) region of the HIV-1 pol gene. Most of the previous studies were restricted to subtype B, although subtype C accounts for more than 50% of HIV infections worldwide. In this study we characterized PR sequences from primary clinical isolates from protease inhibitor (PI)-naive patients in South India (n=39) as well as database-derived HIV-1 subtype C sequences from India (n=542) and globally (n=2970). All the study sequences were identified as subtype C, which is predominant in India. Drug resistance genotyping analysis identified 2.6% (1/39) prevalence of major PI resistance (I54T) and 7.7% (3/39) of minor PI resistance (L10I, T74S, and A71T). Selection of T12S, I15V, L19I, M36I, R41K, H69K, L89M, and I93L was observed both in global and Indian subtype C while the L63P mutation was selected in Indian PR sequences. Three different codon-based maximum likelihood methods agreed on four sites (12, 19, 36, and 82) under positive selection in Indian sequences.

Get full access to this article

View all access options for this article.

References

Neogi

, Sood

, Banerjee

et al. Global HIV-1 Molecular epidemiology with special reference to genetic analysis of HIV-1 subtypes circulating in North India: Functional and pathogenic implications of genetic variation. Indian J Exp Biol, 2009; 57:424–431.

Bennett

, Camacho

, Otelea

et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS ONE, 2009; 4:e4724.

Ayehunie

, Johansson

, Sonnerborg

et al. New subtype of HIV-1 in Ethiopia. Lancet, 1990; 336:942.

Hemelaar

, Gouws

, Ghys

, Osmanov

. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS, 2006; 20:W13–23.

Neogi

, Prarthana

, D'souza

et al. Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India. AIDS Res Ther, 2010; 7:24.

Neogi

, Prarthana

, Gupta

et al. Naturally occurring polymorphisms and primary drug resistance profile among antiretroviral-naïve individuals in Bangalore, India. AIDS Res Hum Retroviruses, 2010; 26:1097–1101.

Pond

SLK

, Frost

SDW

. Not so different after all: A comparison of methods for detecting amino acid sites under selection. Mol Biol Evol, 2005; 22:1208–1222.

Pillai

, Kosakovsky

PSL

, Woelk

et al. Codon volatility does not reflect selective pressure on the HIV-1 genome. Virology, 2005; 336:137–143.

Manosuthi

, Butler

, Perez-Santiago

et al. Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure. AIDS, 2010; 24:411–416.

10.

Deshpande

, Recordon-Pinson

, Deshmukh

et al. Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations. AIDS Res Hum Retroviruses, 2004; 20:1032–1035.

11.

Kandathil

, Kannangai

, Abraham

et al. The frequency of HIV-1 drug resistance mutations among treatment naïve individuals at a tertiary care centre in south India. Int J STD AIDS, 2009; 20:522–526.

12.

Balakrishnan

, Kumarasamy

, Kantor

et al. HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India. AIDS Res Hum Retroviruses, 2005; 21:301–305.

13.

Holguin

, Sune

, Hamy

et al. Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure. J Clin Virol, 2006; 36:264–271.

Characterization of HIV Type 1 Subtype C protease Gene: Selection of L63P Mutation in Protease Inhibitor-Naive Indian Patients

Abstract

Get full access to this article

References